149 related articles for article (PubMed ID: 28212551)
1. NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.
Chen HH; Fan P; Chang SW; Tsao YP; Huang HP; Chen SL
Oncotarget; 2017 Mar; 8(13):21501-21515. PubMed ID: 28212551
[TBL] [Abstract][Full Text] [Related]
2. DDB2 is a novel AR interacting protein and mediates AR ubiquitination/degradation.
Chang SW; Su CH; Chen HH; Huang CW; Tsao LP; Tsao YP; Chen SL
Int J Biochem Cell Biol; 2012 Nov; 44(11):1952-61. PubMed ID: 22846800
[TBL] [Abstract][Full Text] [Related]
3. The cullin 4B-based UV-damaged DNA-binding protein ligase binds to UV-damaged chromatin and ubiquitinates histone H2A.
Guerrero-Santoro J; Kapetanaki MG; Hsieh CL; Gorbachinsky I; Levine AS; Rapić-Otrin V
Cancer Res; 2008 Jul; 68(13):5014-22. PubMed ID: 18593899
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability.
Chen PH; Tsao YP; Wang CC; Chen SL
Nucleic Acids Res; 2008 Jan; 36(1):51-66. PubMed ID: 17984071
[TBL] [Abstract][Full Text] [Related]
5. DDB2, the xeroderma pigmentosum group E gene product, is directly ubiquitylated by Cullin 4A-based ubiquitin ligase complex.
Matsuda N; Azuma K; Saijo M; Iemura S; Hioki Y; Natsume T; Chiba T; Tanaka K; Tanaka K
DNA Repair (Amst); 2005 May; 4(5):537-45. PubMed ID: 15811626
[TBL] [Abstract][Full Text] [Related]
6. DNA damage binding protein component DDB1 participates in nucleotide excision repair through DDB2 DNA-binding and cullin 4A ubiquitin ligase activity.
Li J; Wang QE; Zhu Q; El-Mahdy MA; Wani G; Praetorius-Ibba M; Wani AA
Cancer Res; 2006 Sep; 66(17):8590-7. PubMed ID: 16951172
[TBL] [Abstract][Full Text] [Related]
7. The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites.
Kapetanaki MG; Guerrero-Santoro J; Bisi DC; Hsieh CL; Rapić-Otrin V; Levine AS
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2588-93. PubMed ID: 16473935
[TBL] [Abstract][Full Text] [Related]
8. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes.
Banks D; Wu M; Higa LA; Gavrilova N; Quan J; Ye T; Kobayashi R; Sun H; Zhang H
Cell Cycle; 2006 Aug; 5(15):1719-29. PubMed ID: 16861890
[TBL] [Abstract][Full Text] [Related]
9. The CRL4
Tseng C; Han Y; Lv Z; Song Q; Wang K; Shen H; Chen Z
J Mol Med (Berl); 2023 Feb; 101(1-2):171-181. PubMed ID: 36688959
[TBL] [Abstract][Full Text] [Related]
10. NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors.
Tsai TC; Lee YL; Hsiao WC; Tsao YP; Chen SL
J Biol Chem; 2005 May; 280(20):20000-9. PubMed ID: 15784617
[TBL] [Abstract][Full Text] [Related]
11. Detecting UV-lesions in the genome: The modular CRL4 ubiquitin ligase does it best!
Scrima A; Fischer ES; Lingaraju GM; Böhm K; Cavadini S; Thomä NH
FEBS Lett; 2011 Sep; 585(18):2818-25. PubMed ID: 21550341
[TBL] [Abstract][Full Text] [Related]
12. Small molecule NSC1892 targets the CUL4A/4B-DDB1 interactions and causes impairment of CRL4
Yang C; Wu J; He H; Liu H
Int J Biol Sci; 2020; 16(6):1059-1070. PubMed ID: 32140073
[TBL] [Abstract][Full Text] [Related]
13. Cellular concentrations of DDB2 regulate dynamic binding of DDB1 at UV-induced DNA damage.
Alekseev S; Luijsterburg MS; Pines A; Geverts B; Mari PO; Giglia-Mari G; Lans H; Houtsmuller AB; Mullenders LH; Hoeijmakers JH; Vermeulen W
Mol Cell Biol; 2008 Dec; 28(24):7402-13. PubMed ID: 18936169
[TBL] [Abstract][Full Text] [Related]
14. The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.
Zhang Y; Wang XW; Jelovac D; Nakanishi T; Yu MH; Akinmade D; Goloubeva O; Ross DD; Brodie A; Hamburger AW
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9890-5. PubMed ID: 15994225
[TBL] [Abstract][Full Text] [Related]
15. Upregulated LMO1 in prostate cancer acts as a novel coactivator of the androgen receptor.
Gu H; Liu T; Cai X; Tong Y; Li Y; Wang C; Li F
Int J Oncol; 2015 Dec; 47(6):2181-7. PubMed ID: 26459575
[TBL] [Abstract][Full Text] [Related]
16. Damage-specific DNA binding protein 1 (DDB1): a protein with a wide range of functions.
Iovine B; Iannella ML; Bevilacqua MA
Int J Biochem Cell Biol; 2011 Dec; 43(12):1664-7. PubMed ID: 21959250
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
[TBL] [Abstract][Full Text] [Related]
19. Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis.
Jiang L; Rong R; Sheikh MS; Huang Y
J Biol Chem; 2011 Mar; 286(9):6971-8. PubMed ID: 21205828
[TBL] [Abstract][Full Text] [Related]
20. Artemis interacts with the Cul4A-DDB1DDB2 ubiquitin E3 ligase and regulates degradation of the CDK inhibitor p27.
Yan Y; Zhang X; Legerski RJ
Cell Cycle; 2011 Dec; 10(23):4098-109. PubMed ID: 22134138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
